Literature DB >> 31390266

Sphingosine-1-phosphate signaling in blood pressure regulation.

Suttira Intapad1.   

Abstract

Sphingolipids were originally believed to play a role only as a backbone of mammalian cell membranes. However, sphingolipid metabolites, especially sphingosine-1-phosphate (S1P), are now recognized as new bioactive signaling molecules that are critically involved in numerous cellular functions of multiple systems including the immune system, central nervous system, and cardiovascular system. S1P research has accelerated in the last decade as new therapeutic drugs have emerged that target the S1P signaling axis to treat diseases of the immune and central nervous systems. There is limited knowledge of the specific effects on cardiovascular disease. This review discusses the current state of knowledge regarding the role of S1P on the regulation of blood pressure, vascular tone, and renal functions.

Entities:  

Keywords:  blood pressure; renal function; sphingosine-1-phosphate; vascular tone

Mesh:

Substances:

Year:  2019        PMID: 31390266      PMCID: PMC6766635          DOI: 10.1152/ajprenal.00572.2018

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  38 in total

Review 1.  Signaling of sphingosine-1-phosphate via the S1P/EDG-family of G-protein-coupled receptors.

Authors:  Michael J Kluk; Timothy Hla
Journal:  Biochim Biophys Acta       Date:  2002-05-23

2.  Lysosphingolipid receptor-mediated diuresis and natriuresis in anaesthetized rats.

Authors:  A Bischoff; D Meyer Zu Heringdorf; K H Jakobs; M C Michel
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

3.  Sphingosine-1-phosphate reduces rat renal and mesenteric blood flow in vivo in a pertussis toxin-sensitive manner.

Authors:  A Bischoff; P Czyborra; D Meyer Zu Heringdorf; K H Jakobs; M C Michel
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

Review 4.  Lipid phosphate phosphatases and lipid phosphate signalling.

Authors:  S Pyne; J S Long; N T Ktistakis; N J Pyne
Journal:  Biochem Soc Trans       Date:  2005-12       Impact factor: 5.407

5.  Sphingosine 1-phosphate induces sinus tachycardia and coronary vasoconstriction in the canine heart.

Authors:  A Sugiyama; Y Yatomi; Y Ozaki; K Hashimoto
Journal:  Cardiovasc Res       Date:  2000-04       Impact factor: 10.787

6.  Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1.

Authors:  Mehrdad Matloubian; Charles G Lo; Guy Cinamon; Matthew J Lesneski; Ying Xu; Volker Brinkmann; Maria L Allende; Richard L Proia; Jason G Cyster
Journal:  Nature       Date:  2004-01-22       Impact factor: 49.962

7.  S1P3 receptors mediate the potent constriction of cerebral arteries by sphingosine-1-phosphate.

Authors:  Salvatore Salomone; Shin-ichi Yoshimura; Uwe Reuter; Melissa Foley; Sunu S Thomas; Michael A Moskowitz; Christian Waeber
Journal:  Eur J Pharmacol       Date:  2003-05-23       Impact factor: 4.432

8.  The sphingosine-1-phosphate receptors S1P1, S1P2, and S1P3 function coordinately during embryonic angiogenesis.

Authors:  Mari Kono; Yide Mi; Yujing Liu; Teiji Sasaki; Maria Laura Allende; Yun-Ping Wu; Tadashi Yamashita; Richard L Proia
Journal:  J Biol Chem       Date:  2004-05-11       Impact factor: 5.157

9.  Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes.

Authors:  M Forrest; S-Y Sun; R Hajdu; J Bergstrom; D Card; G Doherty; J Hale; C Keohane; C Meyers; J Milligan; S Mills; N Nomura; H Rosen; M Rosenbach; G-J Shei; I I Singer; M Tian; S West; V White; J Xie; R L Proia; S Mandala
Journal:  J Pharmacol Exp Ther       Date:  2004-01-27       Impact factor: 4.030

10.  Indomethacin differentiates the renal effects of sphingosine-1-phosphate and sphingosylphosphorylcholine.

Authors:  Claudia Czyborra; Angela Bischoff; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-03-07       Impact factor: 3.000

View more
  3 in total

Review 1.  Sphingolipids and Kidney Disease: Possible Role of Preeclampsia and Intrauterine Growth Restriction (IUGR).

Authors:  Rodrigo Yokota; Benjamin Bhunu; Hiroe Toba; Suttira Intapad
Journal:  Kidney360       Date:  2021-01-07

2.  Serum Metabolites Associated with Blood Pressure in Chronic Kidney Disease Patients.

Authors:  Fengyao Yan; Dan-Qian Chen; Jijun Tang; Ying-Yong Zhao; Yan Guo
Journal:  Metabolites       Date:  2022-03-23

3.  Sphingosine 1 phosphate promotes hypertension specific memory T cell trafficking in response to repeated hypertensive challenges.

Authors:  Maha M Itani; Hala Jarrah; Dina Maaliki; Zeina Radwan; Rima Farhat; Hana A Itani
Journal:  Front Physiol       Date:  2022-09-07       Impact factor: 4.755

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.